Response: An In Vitro Model to Probe the Regulation of Adipocyte Differentiation under Hyperglycemia (Diabetes Metab J 2013;37:176-80)

Kusampudi Shilpa; Thangaraj Dinesh; Baddireddi Subhadra Lakshmi

doi:10.4093/dmj.2013.37.4.298

Articles

Page Path: HOME > Diabetes Metab J > Volume 37(4); 2013 > Article

Response Response: An In Vitro Model to Probe the Regulation of Adipocyte Differentiation under Hyperglycemia (Diabetes Metab J 2013;37:176-80): Kusampudi Shilpa, Thangaraj Dinesh, Baddireddi Subhadra Lakshmi; Diabetes & Metabolism Journal 2013;37(4):298-299.
DOI: https://doi.org/10.4093/dmj.2013.37.4.298
Published online: August 14, 2013

2,944 Views
28 Download
1 Scopus

Centre for Biotechnology, Anna University, Chennai, India.

Corresponding author: Baddireddi Subhadra Lakshmi. Centre for Biotechnology, Anna University, Chennai 600025, India. lakshmibs@annauniv.edu

This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.

Full Article

Download PDF

NOTES
REFERENCES

We truly appreciate the interest and comments regarding our study, "An in vitro model to probe the regulation of adipocyte differentiation under hyperglycemia" which was published in Diabetes & Metabolism Journal 2013;37:176-180 [1]. Our response to the comments by Dr. In-Kyung Jeong is:

First, in in vitro studies, the preadipocytes are maintained and differentiated to mature adipocytes using DMEM supplemented with 25 mM glucose (ATCC® CL-173™) [2-4]. Han et al. [5,6] have studied the effect of 5 and 25 mM glucose on differentiation of 3T3-L1 adipocytes and reported that 3T3-L1 adipocytes when grown in 25 mM glucose were hypertrophic with large cells containing considerable numbers of lipid droplets in comparison to the cells maintained in 5 mM glucose. Similar results were observed by us upon treatment of 3T3-L1 adipocytes with 5, 25, 45, 65, 85, and 105 mM glucose concentrations, which showed less lipid accumulation at 5 mM measured using AdipoRed assay.

Our studies have been performed with hypertrophy inducing concentration of glucose (25 mM) as control, and the effect of higher concentrations of glucose on adipogenic markers following hypertrophy, were investigated.

Since the current study has been performed in vitro, the tolerance levels would vary in comparison to in vivo conditions. For instance, in healthy human subjects, LPS circulates in plasma at low concentrations between 1 and 200 pg/mL [7] but various in vitro studies are performed with LPS concentrations of 5, 25, 50, or 75 µg/mL [8,9], which are considered fatal in vivo. Serum tumor necrosis factor α (TNFα) levels is approximately 0.7 pg/mL in normal subjects and 5.1 pg/mL under obese condition [10,11]. The in vitro studies have been performed using 4, 5 ng/mL, and 100 pM TNFα which are considered high concentrations compared to the physiological concentration [8,12,13].

Second, hyperosmotic cell stress has been known to cause cell damage physically and is also known to induce apoptosis [14]. Glucose at 105 mM was not observed to cause cell death, investigated using MTT assay, whereas, glucose at 125 mM was found to be cytotoxic on 3T3L1 adipocytes. Hence the study focused on the non cytotoxic range of glucose concentration (25 to 105 mM glucose).

Overall, the study attempted to investigate the effect of glucose on adipogenesis, in the presence of concentrations exceeding 25 mM glucose, to study the fate of the cells above the hypertrophy inducing concentration of glucose. We hope studies to investigate the effect of mannitol as control, to confirm whether the increase of oxidative stress, cytokine gene expression, nuclear factor-κB, or TNFα, is due to very high concentration of glucose itself or high osmolarity can be performed through this effort. However, our aim was to explore the effect of high glucose concentrations on adipogenesis, which has not been reported earlier, to enable us to understand the mechanism of acute hyperglycemia. Thank you for the interest in this study and for your useful comments.

NOTES

No potential conflict of interest relevant to this article was reported.

REFERENCES

1. Shilpa K, Dinesh T, Lakshmi BS. An in vitro model to probe the regulation of adipocyte differentiation under hyperglycemia. Diabetes Metab J 2013;37:176-180. Article PubMed PMC
2. ATCC®: CL-173™ cited 2013 Aug 1. Available from: http://www.atcc.org/products/all/CL-173.aspx#7301B7F956944F8382B6192957C08A3Bhttp://www.atcc.org/products/all/CL-173.aspx#7301B7F956944F8382B6192957C08A3B.
3. Sangeetha KN, Shilpa K, Jyothi Kumari P, Lakshmi BS. Reversal of dexamethasone induced insulin resistance in 3T3L1 adipocytes by 3β-taraxerol of Mangifera indica. Phytomedicine 2013;20:213-220. Article PubMed
4. Anand S, Muthusamy VS, Sujatha S, Sangeetha KN, Bharathi Raja R, Sudhagar S, Poornima Devi N, Lakshmi BS. Aloe emodin glycosides stimulates glucose transport and glycogen storage through PI3K dependent mechanism in L6 myotubes and inhibits adipocyte differentiation in 3T3L1 adipocytes. FEBS Lett 2010;584:3170-3178. Article PubMed PDF
5. Han CY, Subramanian S, Chan CK, Omer M, Chiba T, Wight TN, Chait A. Adipocyte-derived serum amyloid A3 and hyaluronan play a role in monocyte recruitment and adhesion. Diabetes 2007;56:2260-2273. Article PubMed PDF
6. Han CY, Kargi AY, Omer M, Chan CK, Wabitsch M, O'Brien KD, Wight TN, Chait A. Differential effect of saturated and unsaturated free fatty acids on the generation of monocyte adhesion and chemotactic factors by adipocytes: dissociation of adipocyte hypertrophy from inflammation. Diabetes 2010;59:386-396. PubMed
7. Erridge C, Attina T, Spickett CM, Webb DJ. A high-fat meal induces low-grade endotoxemia: evidence of a novel mechanism of postprandial inflammation. Am J Clin Nutr 2007;86:1286-1292. Article PubMed
8. Song MJ, Kim KH, Yoon JM, Kim JB. Activation of Toll-like receptor 4 is associated with insulin resistance in adipocytes. Biochem Biophys Res Commun 2006;346:739-745. Article PubMed
9. Lu SC, Shieh WY, Chen CY, Hsu SC, Chen HL. Lipopolysaccharide increases resistin gene expression in vivo and in vitro. FEBS Lett 2002;530:158-162. Article PubMed
10. Kapadia SR, Yakoob K, Nader S, Thomas JD, Mann DL, Griffin BP. Elevated circulating levels of serum tumor necrosis factor-alpha in patients with hemodynamically significant pressure and volume overload. J Am Coll Cardiol 2000;36:208-212. Article PubMed
11. Hotamisligil GS, Arner P, Caro JF, Atkinson RL, Spiegelman BM. Increased adipose tissue expression of tumor necrosis factor-alpha in human obesity and insulin resistance. J Clin Invest 1995;95:2409-2415. Article PubMed PMC
12. Chen XH, Zhao YP, Xue M, Ji CB, Gao CL, Zhu JG, Qin DN, Kou CZ, Qin XH, Tong ML, Guo XR. TNF-alpha induces mitochondrial dysfunction in 3T3-L1 adipocytes. Mol Cell Endocrinol 2010;328:63-69. PubMed
13. Kabayama K, Sato T, Kitamura F, Uemura S, Kang BW, Igarashi Y, Inokuchi J. TNFalpha-induced insulin resistance in adipocytes as a membrane microdomain disorder: involvement of ganglioside GM3. Glycobiology 2005;15:21-29. Article PubMed
14. Feng L, Kienitz BA, Matsumoto C, Bruce J, Sisti M, Duong H, Pile-Spellman J. Feasibility of using hyperosmolar mannitol as a liquid tumor embolization agent. AJNR Am J Neuroradiol 2005;26:1405-1412. PubMed PMC

Figure & Data

References

Citations

Citations to this article as recorded by

PubReader

Cite

CITE: export Copy Format; Close

Download Citation

Download a citation file in RIS format that can be imported by all major citation management software, including EndNote, ProCite, RefWorks, and Reference Manager.

Format:

RIS — For EndNote, ProCite, RefWorks, and most other reference management software
BibTeX — For JabRef, BibDesk, and other BibTeX-specific software

Include:

Citation for the content below
Citation and abstract for the content below

Response: An In Vitro Model to Probe the Regulation of Adipocyte Differentiation under Hyperglycemia (Diabetes Metab J 2013;37:176-80)

Diabetes Metab J. 2013;37(4):298-299. Published online August 14, 2013

DOI: https://doi.org/10.4093/dmj.2013.37.4.298

XML Download